Accretive Wealth Partners, LLC Catalent, Inc. Transaction History

Accretive Wealth Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$45.44 - $74.26 $25,037 - $40,917	551 Added 6.61%	8,888 $584,000
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $38,989 - $76,302	942 Added 12.74%	8,337 $375,000
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $21,129 - $33,025	-292 Reduced 3.8%	7,395 $535,000
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $60,691 - $79,378	-696 Reduced 8.3%	7,687 $825,000
Q1 2022 May 12, 2022	BUY	$94.19 - $124.49 $18,555 - $24,524	197 Added 2.41%	8,383 $930,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $20,326 - $23,641	170 Added 2.12%	8,186 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $13,318 - $17,366	122 Added 1.55%	8,016 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $55,287 - $63,745	551 Added 7.5%	7,894 $853,000
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $34,817 - $42,967	343 Added 4.9%	7,343 $773,000
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $601,160 - $737,520	7,000 New	7,000 $728,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Accretive Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Accretive Wealth Partners, LLC with notifications on news.